WATCH NOW
Neurocrine Biosciences | November 2026
On November 4, Neurocrine Biosciences shared information about the upcoming FACET™ study, for the investigational gene therapy NBIB-223.
On November 4, Neurocrine Biosciences shared information about the upcoming FACET™ study, for the investigational gene therapy NBIB-223.